Explore how pyrazole-based compounds are revolutionizing EGFR-targeted cancer therapy through precise molecular design and innovative treatment approaches.
Exploring the biological potential of Organotin (IV) and Pd(II) compounds in modern medicine, particularly their promising anticancer properties.
Exploring how aldehyde and nitro modifications to 1,2,3-triazole compounds enhance their anticancer properties through cell line studies and in silico analysis.